Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 35801 - 35825 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Doxorubicin	Approved Investigational	ABCB1	5243	downregulated	[resveratrol results in increased susceptibility to Doxorubicin] which results in decreased expression of ABCB1 mRNA	7q21.12	A22423
Doxorubicin	Approved Investigational	ABCB4	5244	upregulated	Doxorubicin results in increased expression of ABCB4 mRNA	7q21.12	A22424
Doxorubicin	Approved Investigational	ABCC1	4363	upregulated	Doxorubicin results in increased expression of ABCC1 mRNA	16p13.11	A22418 A22420
Doxorubicin	Approved Investigational	ABCG2	9429	upregulated	Doxorubicin results in increased expression of ABCG2 mRNA	4q22.1	A22425 A21903
Doxorubicin	Approved Investigational	ACTA1	58	downregulated	Doxorubicin results in decreased expression of ACTA1 mRNA	1q42.13	A21904
Doxorubicin	Approved Investigational	ADAM19	8728	downregulated	Doxorubicin results in decreased expression of ADAM19 mRNA	5q33.3	A22419
Doxorubicin	Approved Investigational	ADAMTS5	11096	downregulated	Doxorubicin results in decreased expression of ADAMTS5 mRNA	21q21.3	A22426
Doxorubicin	Approved Investigational	AHCY	191	downregulated	Doxorubicin results in decreased expression of AHCY mRNA	20q11.22	A22419
Doxorubicin	Approved Investigational	ANK2	287	downregulated	Doxorubicin results in decreased expression of ANK2 mRNA	4q25-q26	A21904
Doxorubicin	Approved Investigational	APAF1	317	upregulated	Doxorubicin results in increased expression of APAF1 mRNA	12q23.1	A22427 A21894
Doxorubicin	Approved Investigational	ARHGEF1	9138	upregulated	Doxorubicin results in increased expression of ARHGEF1 mRNA	19q13.2	A22426
Doxorubicin	Approved Investigational	ARHGEF17	9828	upregulated	Doxorubicin results in increased expression of ARHGEF17 mRNA	11q13.4	A22426
Doxorubicin	Approved Investigational	ATF4	468	downregulated	Doxorubicin results in decreased expression of ATF4 mRNA	22q13.1	A22428
Doxorubicin	Approved Investigational	ATM	472	downregulated	Doxorubicin results in decreased expression of ATM mRNA	11q22.3	A22429
Doxorubicin	Approved Investigational	ATP1A2	477	downregulated	Doxorubicin results in decreased expression of ATP1A2 mRNA	1q23.2	A21904
Doxorubicin	Approved Investigational	ATP6V0E1	8992	upregulated	Doxorubicin results in increased expression of ATP6V0E1 mRNA	5q35.1	A22424
Doxorubicin	Approved Investigational	AURKA	6790	downregulated	Doxorubicin results in decreased expression of AURKA mRNA	20q13.2	A22430
Doxorubicin	Approved Investigational	AURKA	6790	upregulated	Doxorubicin results in increased expression of AURKA mRNA	20q13.2	A22431
Doxorubicin	Approved Investigational	AZGP1	563	downregulated	Doxorubicin results in decreased expression of AZGP1 mRNA	7q22.1	A22426
Doxorubicin	Approved Investigational	B4GALT1	2683	downregulated	Doxorubicin results in decreased expression of B4GALT1 mRNA	9p21.1	A22426
Doxorubicin	Approved Investigational	BAX	581	downregulated	Doxorubicin results in decreased expression of BAX mRNA	19q13.33	A21894 A22196 A22432 A22433
Doxorubicin	Approved Investigational	BAX	581	upregulated	Doxorubicin results in increased expression of BAX mRNA	19q13.33	A22427 A22434 A22218 A21904 A22435
Doxorubicin	Approved Investigational	BAX	581	upregulated	[Doxorubicin results in increased phosphorylation of and results in increased activity of TP53 protein] which results in increased expression of BAX mRNA	19q13.33	A22436
Doxorubicin	Approved Investigational	BBC3	27113	upregulated	Doxorubicin results in increased expression of BBC3 mRNA	19q13.32	A22437
Doxorubicin	Approved Investigational	BBC3	27113	upregulated	[Doxorubicin results in increased phosphorylation of and results in increased activity of TP53 protein] which results in increased expression of BBC3 mRNA	19q13.32	A22436

Displaying entries 35801 - 35825 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability